INTELLIGENCE IN ACTION

Patients Are Ready to Talk Dollars with Their Doctors

February 18, 2020

The era of patients as mere passengers on their healthcare journey is over.

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome.

Most patients who skip a medication due to cost say they would have been willing to take a lower-cost alternative if their doctor or nurse had suggested one. This is the definition of a missed opportunity. And many are willing to switch healthcare providers in order to have cost conversations at the point of care.

These and other insights from our recent survey, Prescription Price Transparency and the Patient Experience, show greater demand among patients for cost conversations with healthcare providers at the point of care.

Here are a few highlights:

  • More than half of patients had not taken a medication because it cost too much.
  • Of those who skipped a medication due to cost, 94% would have been willing to take a lower-cost alternative if their doctor or nurse had suggested one.
  • Nearly 70% of millennials say the ability to talk with their provider about prescription cost has a moderate or significant impact on which doctor they choose, compared with 51% of middle-aged patients and 32% of Medicare-age patients.
  • Nearly one-third of (28%) of millennials would be willing to find a new doctor in order to have cost conversations about their prescriptions.

Download the full report to better understand how patients feel about talking to their healthcare providers about the cost of their medications. And learn more about solutions that address these needs from patients and deliver prescription price transparency to the point of care.

Related Articles

October 13, 2020

Maintaining the Integrity of Clinical Decision Support Tools

How many times have you been influenced to purchase one item over another because it either appeared at the top of a search platform, a purveyor recommended it, or the product kept showing up on your social feeds? I know I have more than once. Read more...
September 08, 2020

Turning Personal Experience into Better Patient Outcomes

Luke Forster-Broten, Director of Product Innovation at Surescripts, sat down with me to talk about the importance of having the prescription cost conversation at the point of care—and how that idea helped inspire the development of our Electronic Prior Authorization solution.

Read more...
August 25, 2020

Three Ways Health Plans Can Address Inefficiencies and Medication Adherence

It is well known that Americans are grappling with rising health care costs and that all sectors of the health care industry have a role to play in addressing this issue. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX